Survival after percutaneous transluminal coronary angioplasty in patients with severe left ventricular dysfunction

• Published in: Chest Vol. 105; no. 3; p. 733
• Main Authors: Maiello, L, Colombo, A, Gianrossi, R, Almagor, Y, Finci, L
• Format: Journal Article
• Language: English
• Published: United States 01.03.1994
• Subjects: Angioplasty, Balloon, Coronary - mortality; Coronary Angiography; Coronary Disease - mortality; Coronary Disease - therapy; Female; Follow-Up Studies; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Retrospective Studies; Risk Factors; Stents; Survival Rate; Time Factors; Treatment Outcome; Ventricular Function, Left - physiology
• ISSN: 0012-3692
• DOI: 10.1378/chest.105.3.733

To assess the effects of coronary angioplasty in patients with severe left ventricular dysfunction, the results of procedures, performed between 1987 and 1991, in 100 patients (90 male) with left ventricular function < or = 0.35 (range, 0.20 to 0.35) and anginal symptoms were analyzed. Mean age was 62 +/- 10 years (range, 38 to 85 years). Ninety-five patients had previous myocardial infarction and 27 patients had previous coronary artery bypass grafting. Unstable angina was present in 81 percent of patients. Single-vessel disease was present in 6 patients, double vessel was present in 31 patients, and triple-vessel disease was present in 63 patients. Percutaneous transluminal coronary angioplasty (PTCA) was attempted on 164 vessels, 27 of these with chronic total occlusion. The overall angiographic success rate was 84 percent. Myocardial infarction occurred in four patients, six patients underwent urgent coronary bypass surgery, and seven patients died of cardiac causes. There was a 9 percent incidence of total in hospital mortality. Major complications were significantly more frequent in patients with triple-vessel disease. Clinical success was achieved in 75 patients, 55 of these with incomplete revascularization. Long-term follow-up (mean, 19 +/- 7 months) was available in all patients with clinical success. Thirteen patients had repeated PTCA, 8 patients had coronary surgery, and 13 patients died. In conclusion, in patients with severe left ventricular dysfunction, acute complications and late mortality rate are high. Patients with triple-vessel disease are a higher risk subset and have no long-term benefits by PTCA.